BiotechTube
Home/Harbour BioMed/Ian Y. Liu
IY

Ian Y. Liu

Senior Vice President, Global Head of Business Development & Licensing

Harbour BioMed

Therapeutic Areas

ImmunologyOncologyMetabolic Diseases

Harbour BioMed Pipeline

DrugIndicationPhase
Batoclimab (HBM9161)Myasthenia GravisPhase 3
HBM9378 (SKB378/WIN378)Asthma, COPDPhase 1
HBM7575 (SKB575)Atopic DermatitisIND Filed
HBM2001Inflammatory Bowel Disease (IBD)Discovery
J9003IBDDiscovery
R1065IgA Nephropathy (IgAN)Discovery
OX40L FamilyDermatosisDiscovery
HBM7020Autoimmune DiseasesDiscovery

Leadership Team at Harbour BioMed

JW
Jingsong Wang
Founder, Chairman & Chief Executive Officer
YR
Yiping Rong
Chief Scientific Officer
JX
Jenny Xie
Chief Scientific Officer, Immunology and Head of Global External Innovation
XT
Xiaolu Tao
President of Harbour Therapeutics
RZ
Raymond Zheng
Chief Business Officer
MD
Michael D. Patten
Chief Strategy Officer
BC
Ben Chih
Chief Scientific Officer - Neurosciences, Entrepreneur in Residence, Harbour BioMed US
YC
Youchen Chen
Chief Financial Officer
View full Harbour BioMed profile